Clinical Trials Directory

Trials / Completed

CompletedNCT04798664

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,228 (actual)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

Detailed description

We will conduct a 4-arm randomized trial comparing 4 interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among smokers in underserved demographic groups. The 3,200 participants to be enrolled will be current smokers who are Black, Hispanic, and/or have low socioeconomic status (defined as household income \<200% of the federal poverty line or a high school education or less) or rural residence who are referred for low-dose computed tomography (LDCT) screening at 4 large health systems. All adult patients with LDCT orders will be further screened for eligibility. Eligible patients will enroll with opt-out consent and complete the study using the NIH-funded Way to Health online research portal. The primary outcome will be biochemically confirmed, sustained abstinence from smoking tobacco for 6 months following participants' selected quit dates. Relapse rates will be tracked at 12 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRemoval of Financial BarriersFree access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications
BEHAVIORALFinancial IncentivesFinancial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.
BEHAVIORALMobile Health ApplicationEpisodic future thinking tool to overcome temporal discounting of future

Timeline

Start date
2021-05-17
Primary completion
2024-11-04
Completion
2025-04-29
First posted
2021-03-15
Last updated
2026-02-25
Results posted
2026-02-25

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04798664. Inclusion in this directory is not an endorsement.